Sevillano A, Pérez-Cerdá F, Muñoz J F, Cortés M, del Campo I, Dávila P, Gómez R, García I, Moreno E
Servicio de Anestesia y Reanimación, Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid.
Rev Esp Anestesiol Reanim. 1997 Feb;44(2):62-9.
To evaluate our application of indications, use and benefits of conventional hemodialysis during surgery in patients with advanced liver disease and acute or chronic renal failure undergoing liver transplantation (LP), liver retransplantation (LRT) or combined hepatorenal transplantation (CHRT).
We retrospectively reviewed the cases of 22 patients with advanced liver disease, 11 with acute renal failure and 11 with chronic renal failure. We performed 6 LT, 5 LRT and 11 CHRT. The following data were recorded in the periods before, during and immediately after surgery: metabolic, hemodynamic and coagulation parameters; bicarbonate, calcium and inotropic drug requirements; incidences during reperfusion of the graft; surgical technique used; and survival.
Seven patients (32%) needed hemodialysis, 4 (18%) needed ultrafiltration, 7 (32%) needed both and 4 (18%) required neither. For 6 patients total clamping of the inferior vena cava (ICV) was required with external venovenous bypass. For 8 patients total clamping of the IVC was performed without venovenous bypass. For 8 others IVC clamping was partial with retrohepatic preservation (piggy-back). There were 2 deaths during surgery, 4 more within the first month after surgery and 4 more in the second month. Overall survival was 36.4% among acute patients and 72.7% among CHRT patients.
评估在晚期肝病合并急性或慢性肾衰竭患者接受肝移植(LP)、再次肝移植(LRT)或肝肾联合移植(CHRT)手术期间常规血液透析的适应证应用、使用情况及益处。
我们回顾性分析了22例晚期肝病患者的病例,其中11例为急性肾衰竭,11例为慢性肾衰竭。我们实施了6例肝移植、5例再次肝移植和11例肝肾联合移植。记录手术前、手术期间及手术后即刻的以下数据:代谢、血流动力学和凝血参数;碳酸氢盐、钙及血管活性药物需求;移植肝再灌注期间的发生率;所采用的手术技术;以及生存率。
7例患者(32%)需要血液透析,4例(18%)需要超滤,7例(32%)两者都需要,4例(18%)两者均不需要。6例患者需要在下腔静脉完全阻断(ICV)的情况下进行体外静脉-静脉转流。8例患者在下腔静脉完全阻断时未进行静脉-静脉转流。另外8例患者下腔静脉部分阻断并保留肝后段(背驮式)。手术期间有2例死亡,术后第一个月内又有4例死亡,第二个月再有4例死亡。急性肾衰竭患者的总体生存率为36.4%,肝肾联合移植患者为72.7%。
1)手术期间常规血液透析可行且效果良好;2)常规“高效”血液透析对这些患者比缓慢、持续血液透析或滤过更有效且有用;3)肝肾联合移植患者的生存率与肾功能正常的肝移植患者相似;4)无肝期下腔静脉部分阻断可能会减少超滤需求。